These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1256045)

  • 1. Analysis of a bioassay for circulating tumor cells in two murine malignancies: Correlations with tumor age and extent of metastatic disease.
    Wexler H; Sindelar WF; Ketcham AS
    J Surg Res; 1976 Feb; 20(2):107-13. PubMed ID: 1256045
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
    Talmadge JE; Fidler IJ
    J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental hematogenous metastasis of a fibrosarcoma in animals with and without spleen].
    Krüger G
    Krebsarzt; 1969; 24(5):312-9. PubMed ID: 4314283
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced growth of fibrosarcoma in mice treated with phytohemagglutinin.
    Wagener DJ
    Cancer Res; 1973 Jun; 33(6):1295-300. PubMed ID: 4718679
    [No Abstract]   [Full Text] [Related]  

  • 7. The fate of methylcholanthrene tumor cells in bone: analysis of immune factors in host resistance.
    McLaughlin AP; Kessler WO; Clark PL; Gittes RF
    J Surg Res; 1973 Mar; 14(3):186-92. PubMed ID: 4702159
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrolytic enzyme activities, migratory activity, and in vivo growth and metastatic potential of recent tumor isolates.
    Varani J; Orr W; Ward PA
    Cancer Res; 1979 Jul; 39(7 Pt 1):2376-80. PubMed ID: 445437
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced murine fibrosarcoma.
    Wang N; Yu SH; Liener IE; Hebbel RP; Eaton JW; McKhann CF
    Cancer Res; 1982 Mar; 42(3):1046-51. PubMed ID: 6174210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1974 May; 34(5):997-1004. PubMed ID: 4841969
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 13. A COMPARISON OF SURVIVAL TIME AND EXTENT OF TUMOR METASTASES IN MICE WITH TRANSPLANTED, INDUCED AND SPONTANEOUS TUMORS.
    WEXLER H; MINTON JP; KETCHAM AS
    Cancer; 1965 Aug; 18():985-94. PubMed ID: 14326497
    [No Abstract]   [Full Text] [Related]  

  • 14. The metastatic potential of experimental pulmonary metastases.
    Ketcham AS; Wexler H; Chretien PB
    J Surg Res; 1973 Jul; 15(1):45-52. PubMed ID: 4718014
    [No Abstract]   [Full Text] [Related]  

  • 15. [Circulating neoplasm cells].
    Boeryd B; Knutsson F; Norrby K; Lundin P
    Nord Med; 1970 Nov; 84(45):1439. PubMed ID: 5481051
    [No Abstract]   [Full Text] [Related]  

  • 16. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
    [No Abstract]   [Full Text] [Related]  

  • 17. 1-Butanol extraction and subsequent reconstitution of membrane components which mediate metastatic phenotype.
    LeGrue SJ
    Cancer Res; 1982 Jun; 42(6):2126-34. PubMed ID: 7074594
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
    Mahalingam M; Ugen KE; Kao KJ; Klein PA
    Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients.
    Fidler IJ; Nicolson GL
    J Natl Cancer Inst; 1977 Jun; 58(6):1867-72. PubMed ID: 864765
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin.
    Kripke ML; Gruys E; Fidler IJ
    Cancer Res; 1978 Sep; 38(9):2962-7. PubMed ID: 679204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.